Advertisement
week in cancer news
  • May 31: The Week in Cancer News

    A study finds that oral cancer medication costs for patients covered by Medicare Part D have increased, and the U.S. Food and Drug Administration approves a new targeted therapy for advanced breast cancer.

    by Kate Yandell

  • May 24: The Week in Cancer News

    Unequal access to care appears to be responsible for the elevated mortality rate from prostate cancer in black men, and women with a history of cancer who identify as lesbian or bisexual have reduced access to care.

    by Kate Yandell

  • May 17: The Week in Cancer News

    A study indicates that the Affordable Care Act decreased the proportion of people with a history of cancer who are uninsured, and access to appropriate targeted therapies may be lacking for some patients.

    by Kate Yandell

  • When a Top-Ranked Cancer Center Comes to a Hospital Near You

    Research shows prominent cancer hospitals have different surgical outcomes than their affiliates.

    by Marci A. Landsmann

  • May 10: The Week in Cancer News

    The spread of measles raises concerns among some cancer patients, and a treatment for early-stage HER2-positive breast cancer is approved by the U.S. Food and Drug Administration.

    by Kate Yandell and Bradley Jones

  • Putting Chemotherapy Side Effects on Ice

    A small study shows that keeping ice chips in the mouth during oxaliplatin chemotherapy may prevent cold sensitivity, a common oral side effect.

    by Anna Azvolinsky

  • The Week in Cancer News: May 3

    Prospective CRISPR application targets cancer directly, HER2 testing accessibility poor in many countries.

    by Bradley Jones